Physician profile
Jon Michael Carnahan
NPI 1568959609
$474.58
in general payments reported to CMS, 2019-2025
11 companies · $54.74 in 2025
The $54.74 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.26 · 2021: $252 · 2022: $15.39 · 2023: $91.39 · 2024: $49.01 · 2025: $54.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $195.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $94.84 | 2019-2021 | |
| Boston Scientific Corporation | $77.95 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $62.26 | 2021-2023 | Andexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.35 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $44.10 | 2024-2025 | Zerbaxa, Dificid, Recarbrio |
| Novo Nordisk INC | $37.07 | 2021-2025 | Rybelsus, Ozempic |
| E.R. Squibb & Sons, L.L.C. | $34.79 | 2022-2024 | Eliquis |
| Inari Medical, INC. | $23.08 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $19.04 | 2023 | Linq II |
| Inspire Medical Systems, INC. | $17.86 | 2025 | Inspire |
| Vyne Pharmaceuticals INC. | $13.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Carnahan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.